Ovarian Mucinous Cystadenocarcinoma, also known as mucinous cystadenocarcinoma of ovary, is related to cystadenocarcinoma and mucinous cystadenocarcinoma. An important gene associated with Ovarian Mucinous Cystadenocarcinoma is FSHR (Follicle Stimulating Hormone Receptor), and among its related pathways/superpathways is Hormone ligand-binding receptors. The drugs Bevacizumab and Endothelial Growth Factors have been mentioned in the context of this disorder. Affiliated tissues include ovary and endothelial.